Track topics on Twitter Track topics that are important to you
Celyad has announced no toxicity and stable disease in colorectal cancer patients after just 3 months of its first trial testing CAR-T in solid tumors. After only 3 months of follow-up, Celyad already has positive results for its CAR-T NKR-2 therapy, ...
This awesome article Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Celyad Reports Impressive Preliminary CAR-T Results in Solid TumorsNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...